Status:
RECRUITING
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
Lead Sponsor:
University of Colorado, Denver
Conditions:
Rheumatoid Arthritis
Interstitial Lung Disease
Eligibility:
All Genders
45-90 years
Brief Summary
The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients wit...
Eligibility Criteria
Inclusion
- ≥ 45years old
- Diagnosis of RA using the 2010 American College of Rheumatology (ACR) criteria
Exclusion
- Inability to give informed consent
- Pregnant women
- History of interstitial lung disease
- Evidence of other causes of diffuse parenchymal lung disease such as infection, drug toxicity, other autoimmune processes, etc.
- Subjects over the age of 90 years old or less than 45 years old
Key Trial Info
Start Date :
June 22 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT03297775
Start Date
June 22 2017
End Date
June 1 2027
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado - Anschutz Medical Campus
Aurora, Colorado, United States, 80045